|
SLC35B4 |
solute carrier family 35 member B4 |
- Transport of nucleotide sugars
|
|
|
|
SLC35E4 |
solute carrier family 35 member E4 |
|
|
|
|
SLC38A7 |
solute carrier family 38 member 7 |
|
|
|
|
SMCO4 |
single-pass membrane protein with coiled-coil domains 4 |
|
|
|
|
SMIM1 |
small integral membrane protein 1 (Vel blood group) |
|
|
|
|
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
- SOS-mediated signalling
- SOS-mediated signalling
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB4 signaling
- Signaling by SCF-KIT
- Regulation of KIT signaling
- Signalling to RAS
- Signalling to RAS
- GRB2 events in EGFR signaling
- SHC1 events in EGFR signaling
- Downstream signal transduction
- NRAGE signals death through JNK
- Rho GTPase cycle
- GRB2 events in ERBB2 signaling
- GRB2 events in ERBB2 signaling
- Tie2 Signaling
- EGFR Transactivation by Gastrin
- DAP12 signaling
- SHC-related events triggered by IGF1R
- SHC-related events triggered by IGF1R
- Role of LAT2/NTAL/LAB on calcium mobilization
- Role of LAT2/NTAL/LAB on calcium mobilization
- FCERI mediated MAPK activation
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- NCAM signaling for neurite out-growth
- G alpha (12/13) signalling events
- Activation of RAC1
- Constitutive Signaling by EGFRvIII
- SHC-mediated cascade:FGFR1
- FRS-mediated FGFR1 signaling
- SHC-mediated cascade:FGFR2
- FRS-mediated FGFR2 signaling
- SHC-mediated cascade:FGFR3
- FRS-mediated FGFR3 signaling
- FRS-mediated FGFR4 signaling
- SHC-mediated cascade:FGFR4
- Signaling by FGFR2 in disease
- Signaling by FGFR4 in disease
- Signaling by FGFR1 in disease
- RAF/MAP kinase cascade
- Signal attenuation
- Insulin receptor signalling cascade
- Insulin receptor signalling cascade
- MET activates RAS signaling
- Signaling by FGFR3 fusions in cancer
- Signaling by FGFR3 point mutants in cancer
- RET signaling
- Interleukin-15 signaling
- Activated NTRK2 signals through RAS
- Erythropoietin activates RAS
- Activated NTRK2 signals through FRS2 and FRS3
- Activated NTRK2 signals through FRS2 and FRS3
- Activated NTRK3 signals through RAS
- Interleukin receptor SHC signaling
- FLT3 Signaling
- Constitutive Signaling by Overexpressed ERBB2
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 ITD and TKD mutants
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
- Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
|
|
TECR |
trans-2,3-enoyl-CoA reductase |
- Synthesis of very long-chain fatty acyl-CoAs
|
|
|
|
TM6SF2 |
transmembrane 6 superfamily member 2 |
|
|
|
|
TMEM11 |
transmembrane protein 11 |
|
|
|
|
TMEM120B |
transmembrane protein 120B |
|
|
|
|
TMEM121 |
transmembrane protein 121 |
|
|
|
|
TMEM128 |
transmembrane protein 128 |
|
|
|
|
TMEM147 |
transmembrane protein 147 |
|
|
|
|
TMEM14A |
transmembrane protein 14A |
|
|
|
|
TMEM14C |
transmembrane protein 14C |
|
|
|
|
TMEM187 |
transmembrane protein 187 |
|
|
|
|
TMEM229B |
transmembrane protein 229B |
|
|
|
|
TMEM243 |
transmembrane protein 243 |
|
|
|
|
TMEM86A |
transmembrane protein 86A |
|
|
|
|
TMEM86B |
transmembrane protein 86B |
- Acyl chain remodelling of PC
|
|
|